In hepatocellular carcinoma [8], MBD3 promotes metastasis by inhibiting the tumour suppressor tissue factor pathway inhibitor 2, while MBD3 inhibited epithelial-mesenchymal transition (EMT) via TGF-β/Smad signalling in pancreatic cancer cells [9]. The gene discussed is MBD3; the disease is hepatocellular carcinoma.